Surface Logix Grabs $4M

Xconomy Boston — 

Surface Logix, a Brighton, MA-based developer of drugs for obesity and diabetes, pulled in $4 million in an offering of equity, options, and warrants that could total $4.6 million, according to an SEC filing. The startup, which launched in 2001 with technology from Harvard chemist George Whitesides, raised $20 million in Series E funding last year, with backing from Arch Venture Partners, HBM BioVentures, Healthcare Focus, Intel Capital, Saudi Venture Development, Unilever Technology Ventures, and Venrock Associates.The filing for the newest funding for Surface lists 17 investors.